Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial(Journal of Headache and Pain (2018)19:98 DOI: 10.1186/s10194-018-0928-1)

Licia Grazzi, Cristina Tassorelli, Marina De Tommaso, Giulia Pierangeli, Paolo Martelletti, Innocenzo Rainero, Pierangelo Geppetti, Anna Ambrosini, Paola Sarchielli, Eric Liebler, Piero Barbanti

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], the authors notified us that a part of the Figure 3 legend was omitted during the proofing stage. The original publication has been corrected. The incorrect and correct figure legends are presented below. Originally published legend for Figure 3: =1-Point Reduction in Pain Intensity at 30, 60, and 120 Minutes for (a) First Attack and (b) All Attacks .Corrected Figure 3 legend: =1-Point Reduction in Pain Intensity at 30, 60, and 120 Minutes for (a) First Attack and (b) All Attacks. Models are adjusted for the patients' baseline pain score, use of preventive therapies, and presence of aura; data for number of patients are unadjusted numbers. Abbreviation: nVNS, non-invasive vagus nerve stimulation.

Original languageEnglish
Article number1
JournalJournal of Headache and Pain
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 7 2019

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial(Journal of Headache and Pain (2018)19:98 DOI: 10.1186/s10194-018-0928-1)'. Together they form a unique fingerprint.

Cite this